Treats nosocomial pneumonia due to methicillin-susceptible Staphylococcus aureus…. ANDA 78424, held by Lupin. Levofloxacin.
As of Nov 16, 2026, ANDA 78424 (Levofloxacin), held by Lupin, was first approved by FDA on Jun 20, 2011, with 14 approved supplements and 0 published complete response letters.
Levofloxacin is a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with infections caused by designated, susceptible bacteria and in pediatric patients where indicated ( 1, 12.4 ). Pneumonia: Nosocomial and Community Acquired ( 1.2, 1.3 ) Skin and Skin Structure Infections (SSSI): Complicated and Uncomplicated Chronic bacterial prostatitis Inhalational Anthrax, Post-Exposure in adult and pediatric patients Plague in adult and pediatric patients Urinary Tract Infections (UTI): Complicated (1.9, 1.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 20, 2011 | Original application | Approved | None posted |
| Levofloxacin250MG · tablet;oral | Levofloxacin | Discontinued |
| Levofloxacin500MG · tablet;oral | Levofloxacin | Discontinued |
| Levofloxacin750MG · tablet;oral | Levofloxacin | Discontinued |
| Sep 20, 2024 | Supplement 22Labeling · Standard review | Approved | None posted |
| Dec 19, 2022 | Supplement 21Labeling · Standard review | Approved | None posted |
| Jun 10, 2020 | Supplement 20Labeling · Standard review | Approved | None posted |
| Jun 10, 2020 | Supplement 19Labeling · Standard review | Approved | None posted |
| May 3, 2019 | Supplement 18Labeling · Standard review | Approved | None posted |
| Apr 17, 2019 | Supplement 17Labeling · Standard review | Approved | None posted |
| Apr 17, 2019 | Supplement 16Labeling · Standard review | Approved | None posted |
| Apr 17, 2019 | Supplement 14Labeling · Standard review | Approved | None posted |
| Apr 17, 2019 | Supplement 13Labeling · Standard review | Approved | None posted |
| Nov 8, 2014 | Supplement 11Labeling · Standard review | Approved | None posted |
| Nov 8, 2014 | Supplement 10Labeling · Standard review | Approved | None posted |
| Apr 8, 2013 | Supplement 8Labeling · Standard review | Approved | None posted |
| Mar 8, 2013 | Supplement 7Labeling · Standard review | Approved | None posted |
| Jan 18, 2012 | Supplement 1Labeling | Approved | None posted |
| Jun 20, 2011 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters